Report overview
Tuberculosis (TB) vaccines are vaccinations intended for the prevention of tuberculosis. Immunotherapy as a defence against TB was first proposed in 1890 by Robert Koch. Today, the only effective tuberculosis vaccine in common use is bacilli Calmette-Gu?rin (BCG), first used in 1921.About three out of every 10,000 people who get the vaccine experience side effects, which are usually minor except in severely immuno-depressed individuals. While BCG immunization provides fairly effective protection for infants and young children, (including defence against TB meningitis and miliary TB), its efficacy in adults is variable, ranging from 0% to 80%.Several variables have been considered as responsible for the varying outcomes. Demand for TB immunotherapy advancement exists because the disease has become increasingly drug-resistant.
This report aims to provide a comprehensive presentation of the global market for TB Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding TB Vaccines. This report contains market size and forecasts of TB Vaccines in global, including the following market information:
Global TB Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global TB Vaccines Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five TB Vaccines companies in 2022 (%)
The global TB Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Immunotherapeutic Vaccines Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of TB Vaccines include Merck & Co.,Inc, Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute, India Pvt. Ltd, InterVax Ltd, GreenSignal and Bio Pharma Limited, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the TB Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global TB Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global TB Vaccines Market Segment Percentages, by Type, 2022 (%)
Immunotherapeutic Vaccines
Booster Vaccines
Others
Global TB Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global TB Vaccines Market Segment Percentages, by Application, 2022 (%)
Hospitals
Private Clinics
Research Institutes
Global TB Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global TB Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies TB Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies TB Vaccines revenues share in global market, 2022 (%)
Key companies TB Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies TB Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck & Co.,Inc
Sanofi Pasteur
Japan BCG Laboratory
China National Biotec Group
Serum Institute
India Pvt. Ltd
InterVax Ltd
GreenSignal
Bio Pharma Limited
Statens Serum Institut
Outline of Major Chapters:
Chapter 1: Introduces the definition of TB Vaccines, market overview.
Chapter 2: Global TB Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of TB Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of TB Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global TB Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
